20mg Librela Solution for Dogs – 2 Vials

Description

Librela 20mg also demonstrates excellent compatibility with other medications, minimal side effects, and was well-tolerated in studies involving RIMADYL®. Furthermore, it’s suitable for dogs as young as six weeks, and those who may find oral medications challenging, making it a versatile option for all.

With four out of ten dogs likely to show signs of osteoarthritis, early detection and proactive treatment are key to enhancing the quality of life for your canine companions. Choose Librela for a more natural, effective, and long-term solution to osteoarthritis pain management.

Each vial of 1ml Librela contains 20mg bedinvetmab. 20mg Librela is a caninised monoclonal antibody.

Librela is used for the alleviation of pain associated with osteoarthritis in Dogs.

Usage Instructions

• Administration Route: Subcutaneous injection
• Dosage: The dosage may vary based on the dog’s weight and the severity of symptoms as determined by a veterinarian, but typically a monthly injection regimen is recommended.
• Precautions: It is important to use this product under the guidance of a veterinarian. Regular monitoring for any adverse reactions or changes in health conditions should be conducted.

Benefits

• Provides effective and long-lasting pain relief.
• Improves quality of life by enhancing mobility and activity levels.
• Targeted action minimizes general systemic effects, making it a safer choice for long-term use in managing osteoarthritic pain.